
AIM ImmunoTech fell 89.8% from $1.46 to $0.15, behind the S&P 500's +12.3%. Its worst day was May 8 (−39.7%), and its low came Nov 10 at $0.14.
Nov 13, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-1.57 missed the $-0.98 estimate on $26,000.00 revenue.
−7.6% · S&P 500 −0.8%
AIM ImmunoTech shares rose 58.2%, while the S&P 500 rose 0.1%.
Story events cover the past 12 months · Times ET
+58.2% · S&P 500 +0.1%
AIM ImmunoTech shares rose 43.7%, while the S&P 500 fell 1.4%.
+43.7% · S&P 500 −1.4%
EPS of $-1.44 missed the $-1.08 estimate on $21,000.00 revenue.
+1.2% · S&P 500 −1.7%
AIM ImmunoTech shares fell 39.7%, while the S&P 500 rose 0.8%.
−39.7%, the year's worst day · S&P 500 +0.8%
EPS of $-0.69 was reported on $22,000.00 revenue.
+61.3% · S&P 500 −0.1%
AIM ImmunoTech shares rose 120.4%, while the S&P 500 rose 0.3%.
+120.4%, the year's best day · S&P 500 +0.3%
EPS of $-0.43 missed the $-0.12 estimate on $26,000.00 revenue.
−7.8% · S&P 500 0.0%
Where it ended: a close of $0.15 on Nov 12, 2026.
Nothing in the past 12 months.
All AIM dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for AIM and SPY from Benzinga historical bars. Not investment advice.